<unk>  is a putative general antibody marker for<unk> t cancers, and the basis for a cancer screening test marketed by Oncolab of Boston, Mass. Initial claims for the effectiveness of the test emerged in the refereed literature in the mid-1990s. However, the diagnostic efficacy of the test, as determined by its sensitivity and specificity has since been disputed
Anti-malignin antibody
Anti-neutrophil cytoplasmic antibody
Anti-nuclear antibody
Anti-LKM antibody
Antisperm antibodies
Anti-histone antibodies
Anti-gliadin antibodies
Anti–Saccharomyces cerevisiae antibody